APP-FUBINACA
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1185282-03-4 |
PubChem | CID: 58124515 |
Chemical data | |
Formula | C24H21FN4O2 |
Molecular mass | 416.5 g/mol |
|
|
|
APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.[1] Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested.[2]
Legality
Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.[3]
See also
<templatestyles src="Div col/styles.css"/>
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Indazoles
- Cannabinoids
- Designer drugs
- Indazolecarboxamides
- Fluoroarenes
- Cannabinoid stubs